Advances in immunotherapy for melanoma.

Redman, Jason M; Gibney, Geoffrey T; Atkins, Michael B

Redman, Jason M; Gibney, Geoffrey T; Atkins, Michael B.

Affiliation

Redman JM; Georgetown Lombardi Comprehensive Cancer Center 3970 Reservoir Road, NW Research Building, Room E501, 20007, Washington DC, USA. jason.m.redman@gmail.com.
Gibney GT; Department of Medicine, Georgetown University Medical Center, Washington DC, USA. jason.m.redman@gmail.com.
Atkins MB; Georgetown Lombardi Comprehensive Cancer Center 3970 Reservoir Road, NW Research Building, Room E501, 20007, Washington DC, USA. geoffrey.t.gibney@gunet.georgetown.edu.

BMC Med ; 14: 20, 2016 Feb 06.

Article in En | MEDLINE | ID: mdl-26850630

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Immunotherapy/methods; Melanoma/drug therapy; CTLA-4 Antigen; Combined Modality Therapy; Contraindications; Disease-Free Survival; Humans; Ipilimumab; Melanoma/immunology; Melanoma/pathology; Nivolumab; Programmed Cell Death 1 Receptor/antagonists & inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Med Journal subject: MEDICINA Year: 2016 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google